1. Shan DE, Wu HC, Chan LY, Liu KD. (2011). Cost-utility analysis of Parkinson's disease. Acta Neurologica Taiwanica 20(1):65-72.
2. Shan DE, Wu HC, Chan LY, Liu KD. (2011). Cost-utility analysis of Parkinson's disease. Acta Neurologica Taiwanica 20(1):65-72.
3. Gustavsson A, Cattelin F, Jonsson L. (2011). Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants. Alzheimer's and Dementia 7(4):466-73.
4. Hakkaart-van Roijen L, Goettsch WG, Ekkebus M, Gerretsen P, et al. (2011). The cost-effectiveness of an intensive treatment protocol for severe dyslexia in children. Dyslexia: the Journal of the British Dyslexia Association 17(3):256-67.
5. Ndosi M, Lewis M, Hale C, Quinn H, et al. (2011). A randomised, controlled study of outcome and cost effectiveness for RA patients attending nurse-led rheumatology clinics: study protocol of an ongoing nationwide multi-centre study. International Journal of Nursing Studies 48(8):995-1001.
6. Hakkaart-van Roijen L, Goettsch WG, Ekkebus M, Gerretsen P, et al. (2011). The cost-effectiveness of an intensive treatment protocol for severe dyslexia in children. Dyslexia: the Journal of the British Dyslexia Association 17(3):256-67.
7. Gustavsson A, Cattelin F, Jonsson L. (2011). Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants. Alzheimer's and Dementia 7(4):466-73.
8. Hakkaart-van Roijen L, Goettsch WG, Ekkebus M, Gerretsen P, et al. (2011). The cost-effectiveness of an intensive treatment protocol for severe dyslexia in children. Dyslexia: the Journal of the British Dyslexia Association 17(3):256-67.
9. Turner D, Raftery J, Cooper K, Fairbank E, et al. (2011). The CHD challenge: comparing four cost-effectiveness models. Value in Health 14(1):53-60.
10. Shan DE, Wu HC, Chan LY, Liu KD. (2011). Cost-utility analysis of Parkinson's disease. Acta Neurologica Taiwanica 20(1):65-72.
